A type of deer antler polypeptide that promotes wound healing

By preparing and applying deer antler polypeptides, the problem of existing wound healing drugs being unable to simultaneously address multiple healing stages has been solved, achieving rapid and effective wound repair, promoting collagen synthesis and immune regulation, and reducing scar formation.

CN116836239BActive Publication Date: 2026-11-17LANZHOU INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310851255.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2022-12-12
Filing Date
2023-07-12
Publication Date
2026-11-17
Estimated Expiration
2043-07-12

AI Technical Summary

Technical Problem

Existing wound healing medications are unable to address multiple healing stages simultaneously, leading to delayed healing of chronic wounds or an inability to effectively promote wound repair.

Method used

The preparation method of deer antler polypeptide includes crushing deer antler, homogenizing, adjusting pH value, adding protease for enzymatic hydrolysis, centrifugation, ultrafiltration and purification to obtain polypeptides with molecular weight between 500-2000 Da, which can be used to prepare skin damage repair drugs and cosmetics.

Benefits of technology

Deer antler polypeptides significantly promote wound healing by rapidly forming a closed space and reducing wound infection through anti-inflammatory effects, regulation of cytokines, promotion of collagen secretion, and inhibition of scar formation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116836239B_ABST
    Figure CN116836239B_ABST
Patent Text Reader

Abstract

This invention provides a deer antler polypeptide with wound-healing properties. The process involves pulverizing deer antler, homogenizing it with water to form a homogenate, adjusting the pH of the homogenate to 6.0–7.5, adding protease for enzymatic hydrolysis, centrifuging the resulting hydrolysate, and then passing the supernatant through an ultrafiltration membrane to remove the portion with a molecular weight below 3 kDa. This hydrolysate is then purified using a Sephadex G25 filtration system to obtain the deer antler polypeptide. The deer antler polypeptide extract provided by this invention exhibits significant efficacy in promoting wound healing and skin repair. It can induce the production of the protein peptide Pro-Hyp and various inflammatory cytokines at the wound site, promote collagen synthesis at the wound site, prevent scar formation, and possesses multiple functions including immunomodulation and promoting epidermal re-epithelialization. It also rapidly forms a sealed space to prevent wound infection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biomedical technology, specifically relating to a deer antler polypeptide that promotes wound healing, its preparation method, and its application. Background Technology

[0002] Currently, there are as many as 13 million patients with chronic wounds in my country. Typical chronic wounds are mainly caused by diseases such as diabetes, lower extremity venous ulcers, and stomas. Among them, the typical characteristics of diabetic foot are local skin and deep tissue destruction, accompanied by wound ulceration and recurrence. About 20% of diabetic patients even face the risk of amputation. Therefore, there is a huge market demand for safe and effective wound repair products.

[0003] Skin injury healing is a dynamic and highly regulated process involving cellular, humoral, and molecular mechanisms. The wound healing process is divided into four phases: coagulation, inflammation, repair, and maturation. It involves immune cells, keratinocytes, fibroblasts, hair follicle stem cells, and other cells. Abnormalities in the function of these cells or insufficient numbers of repair cells often lead to delayed wound healing or chronic wounds. Currently available wound healing promotion drugs are designed according to these four phases and cannot simultaneously address multiple phases to exert their effects.

[0004] Deer antler contains over 60% crude protein by dry weight, particularly rich in collagen, IGF-1, EGF, and NGF, exhibiting significant bioactivities such as promoting bone development, immune regulation, epidermal cell proliferation, and nerve regeneration. Compared to deer antler protein, deer antler active peptides have advantages such as good tissue permeability and weak immunogenicity. Furthermore, due to their small molecular size, they can directly act on key sites, showing significant therapeutic effects on skin injuries and possessing great development potential. Studies have shown that treating rat skin wounds with deer antler peptides using simple injection, simple topical application, and a combination of intramuscular injection and topical application significantly promotes wound healing, regardless of whether it is injection or topical application, thus verifying the wound-healing ability of deer antler peptides. Therefore, the preparation of peptides from deer antler crude protein has gained recognition in the medical field. However, research on the multi-functional activities of deer antler has primarily focused on its antioxidant and bone-healing activities, while methods for preparing peptides with wound-healing activity are rarely reported. Therefore, determining a method for preparing deer antler peptides with wound-healing activity is a key direction for industry development. Summary of the Invention

[0005] The purpose of this invention is to provide a deer antler polypeptide with wound healing properties, its preparation method and application. The deer antler provided has wound repair effects, and its main therapeutic effects include anti-inflammatory, cytokine regulation, wound healing promotion and scar inhibition activities.

[0006] The deer antler polypeptide provided by this invention is prepared by the following method:

[0007] The deer antler was crushed and homogenized with water to form a homogenate. The pH of the homogenate was then adjusted to 6.0–7.5, and protease was added for enzymatic hydrolysis. The resulting hydrolysate was centrifuged, and the upper layer of hydrolysate was passed through an ultrafiltration membrane. Hydrolysate with a molecular weight of less than 3 kDa was then purified using Sephadex G25 to obtain deer antler polypeptide.

[0008] The homogenization process involves preparing a homogenate solution using high-speed shear homogenization at a speed of 8000-10000 rpm for 60-90 seconds.

[0009] The enzymatic hydrolysis mentioned above involves using trypsin and neutral protease to hydrolyze the homogenate.

[0010] As a specific example, the enzymatic hydrolysis is performed at 50°C for 5 hours.

[0011] Furthermore, in the aforementioned deer antler polypeptide, the amino acid sequence of one of the polypeptides is GGYDESMPDPLPEFTE (SEQ ID NO:1).

[0012] The deer antler polypeptide prepared by this invention promotes wound healing. The polypeptide molecular weight is mainly between 500-2000 Da and is composed of proline, aspartic acid, glycine, serine, tyrosine, phenylalanine, arginine, isoleucine, methionine, glutamic acid and valine. It can effectively improve the wound healing speed and the secretion of inflammatory factors and collagen at the wound site.

[0013] In another aspect, the present invention also protects the application of the provided deer antler polypeptide in the preparation of drugs and cosmetics related to the repair of damage to the superficial or dermal layers of the skin.

[0014] The present invention also provides a pharmaceutical composition comprising the aforementioned deer antler polypeptide and pharmaceutically acceptable excipients.

[0015] The pharmaceutical compositions of the present invention can be formulated into conventional dosage forms in the art, including but not limited to oral powders, tablets, capsules, granules, pills, dispersible powders, aqueous or oily suspensions, aqueous or oily solutions, emulsions, syrups, etc., and creams, ointments, gels, aqueous or oily solutions, aqueous or oily suspensions, etc. suitable for topical use.

[0016] The deer antler polypeptide extract provided by this invention has significant effects in promoting wound healing and skin repair. It can induce the production of protein peptide Pro-Hyp and various inflammatory cytokines at the wound site, promote collagen synthesis at the wound site, prevent scar formation, and has multiple effects such as immune regulation and promoting epidermal re-epithelialization. It can also quickly form a closed space to prevent wound infection. Attached Figure Description

[0017] Figure 1 Photograph of skin tissue stained with hematoxylin and eosin (HE). Detailed Implementation

[0018] In previous experiments, direct use of deer antler powder had a certain effect on promoting wound healing, but the amount used was relatively large. Therefore, this invention separates and purifies deer antler powder to obtain a deer antler polypeptide extract with better effects. When used for skin repair, it can promote wound healing faster and reduce the chance of wound infection.

[0019] The present invention will now be described in detail with reference to the embodiments.

[0020] Example 1: Preparation of deer antler polypeptide extract

[0021] Take 1 kg of deer antler, chop it into small pieces, crush it, and pass it through a 100-mesh sieve. Add distilled water at a weight ratio of 1:10. Homogenize the mixture using high-speed shearing at 8000-10000 rpm for 60-90 seconds, repeating this process three times to break up the antler and allow the cellular contents to flow out. Adjust the pH to 6.8, and add trypsin and neutral protease at a mass ratio of 1:1, with a protease addition of 5%. Incubate the mixture at 50℃ for 5 hours. After inactivation, inactivate the enzyme in a boiling water bath (90℃) for 10 minutes, cool, and centrifuge at 8000 rpm for 10 minutes. Pass the supernatant through an ultrafiltration membrane to obtain the hydrolysate with a molecular weight below 3 kDa. Concentrate under reduced pressure and freeze-dry.

[0022] The proteolytic product of deer antler was dissolved in distilled water to a concentration of 100 mg / mL. Separation and purification were performed by Sephadex G25 gel chromatography (2.0 cm × 100 cm) with distilled water as the mobile phase and an elution rate of 0.5 mL / min. The eluent was collected. The eluent was then concentrated under vacuum and freeze-dried to obtain deer antler polypeptides with wound-healing properties. 0.11 kg of deer antler polypeptide extract was obtained, with a yield of 11%.

[0023] The relative molecular weight distribution of the peptides was determined by gel permeation chromatography. 92% of the deer antler peptides had a molecular weight less than 2000 Da, and were distributed between 500 and 2000 Da. The amino acid composition of the deer antler peptides was determined using a fully automated amino acid analyzer. The results showed that the deer antler peptides contained proline, aspartic acid, glycine, serine, tyrosine, phenylalanine, arginine, isoleucine, methionine, glutamic acid, and valine.

[0024] Example 2: Preparation of Deer Antler Polypeptide Extract

[0025] Take 5 kg of deer antler, chop it into small pieces, crush it, and pass it through a 100-mesh sieve. Add distilled water at a weight ratio of 1:10, and homogenize it using high-speed shearing at 8000-10000 rpm for 60-90 seconds. Shear the deer antler three times to break it up and allow the cell contents to flow out. Adjust the pH to 6.8, add trypsin and neutral protease in a 1:1 ratio (content 5%), and hydrolyze at 50℃ for 5 h. After hydrolysis, inactivate the enzyme in a boiling water bath (90℃) for 10 min, cool, centrifuge at 8000 rpm for 10 min, pass the upper hydrolysate through an ultrafiltration membrane, and collect the hydrolysate with a molecular weight below 3 kDa. Concentrate under reduced pressure and freeze-dry.

[0026] The proteolytic product of deer antler was dissolved in distilled water to a concentration of 100 mg / mL. Separation and purification were performed by Sephadex G25 gel chromatography (2.0 cm × 100 cm) with distilled water as the mobile phase and an elution rate of 0.5 mL / mL. The eluent was collected. The eluent was then concentrated under vacuum and freeze-dried to obtain deer antler polypeptides with wound-healing properties. 0.45 kg of deer antler polypeptide extract was obtained, with a yield of 9.0%.

[0027] The relative molecular weight distribution of peptides was determined by gel permeation chromatography. 88% of the deer antler peptides had a molecular weight less than 2000 Da, and were distributed between 500 and 2000 Da.

[0028] Comparative Example 3:

[0029] Take 1 kg of deer antler, chop it into small pieces, crush it, and pass it through a 100-mesh sieve. Add distilled water at a weight ratio of 1:10, and homogenize it using high-speed shearing at 8000-10000 rpm for 60-90 seconds. Shear the deer antler three times to break it up and allow the cellular contents to flow out. Adjust the pH to 6.8, add alkaline protease (5%), and hydrolyze at 50 ℃ for 5 h. After hydrolysis, inactivate the enzyme in a boiling water bath (90 ℃) for 10 min, cool, and centrifuge at 8000 rpm for 10 min. Pass the supernatant through an ultrafiltration membrane to remove the hydrolysate with a molecular weight below 3 kDa, concentrate under reduced pressure, and freeze-dry. Obtain 0.26 kg of deer antler polypeptide extract.

[0030] Example 4: Study on wound healing effect in mice

[0031] Mice were anesthetized intravenously with 1 mL / kg of 3% sodium pentobarbital. After skin preparation of the mouse back, the surgical area was disinfected with 75% ethanol. A circular full-thickness skin defect model with a diameter of 6 mm was prepared in the surgical area on the back. After successful modeling, 20 μL of the deer antler polypeptide extract obtained in Example 1, the deer antler polypeptide extract obtained in Example 3, and physiological saline were injected at 3, 6, 9, and 12 times the center and edge of the circular full-thickness skin defect. After successful administration, the wound was covered with 3M excipients, and the dressing was changed every other day. On the 10th day after modeling, a full-thickness skin sample was taken 3 mm from the outer periphery of the wound, divided in half from the middle, and fixed overnight with 4% paraformaldehyde. After dehydration and embedding, paraffin sections were prepared for HE staining. The wound area was measured using ImageJ software. The healing rate was calculated as (wound area before drug administration - daily wound area) / wound area before drug administration.

[0032] The results showed that the wound healing rate of the deer antler polypeptide group (Example 1) was (76.9±10.1)%, significantly higher than that of the blank control group (33.3±4.5)%, indicating that the wound had basically healed completely. Therefore, the deer antler polypeptide of this invention can promote wound healing, shorten the wound healing time, and has a good therapeutic effect on large-area wounds.

[0033] HE staining results of mouse wound tissue are shown in the figure. Figure 1 As shown in the figure, the 3-day blank control group still had a large number of inflammatory cells infiltrating, while the deer antler polypeptide group had new capillary formation; the 9-day blank control group had only a small amount of loose granulation tissue and capillary formation, while the granulation tissue of the deer antler polypeptide group (Example 1) was arranged in a more orderly and compact manner; the staining results indicate that deer antler polypeptide can promote the formation of capillaries and granulation tissue, thereby promoting wound healing.

[0034] Furthermore, compared with the deer antler polypeptide obtained in Example 1, the wound healing rate of the deer antler polypeptide obtained by hydrolysis with alkaline protease was only 58.0±9.50%, which was much lower than that of the deer antler polypeptide obtained in Example 1, indicating that trypsin and neutral protease have a significant healing-promoting ability when hydrolyzing deer antler polypeptide.

[0035] Table 1: Wound Healing Rate Table

[0036] Group wound healing rate Blank control group 33.3±4.5% Deer antler polypeptide group (Example 1) <![CDATA[76.9±10.1% ** <!-- 3 -->]]> Deer antler polypeptide group (Comparative Example 3) <![CDATA[58.0±9.50% * ]]>

[0037] Compared with the blank control, * P < 0.05 ** P < 0.05.

[0038] Example 5: Effects of trauma-induced immune regulation factors and collagen production in mice

[0039] Hydroxyproline is a specific component of collagen and can be used for collagen quantification. Hydroxyproline content was determined according to the instructions of the hydroxyproline kit (alkaline hydrolysis method) developed by Nanjing Jiancheng. ELISA kits were used to compare the levels of mouse inflammatory markers: interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α).

[0040] The results are shown in Table 2. Compared with the blank control group, the hydroxyproline content at the wound site was significantly increased after administration of the deer antler polypeptide in Example 1 (P < 0.05), indicating that the deer antler polypeptide can promote collagen synthesis at the wound site. Furthermore, the serum levels of TNF-α and IL-1β in the blank control group were significantly increased, while after administration of the deer antler polypeptide, the levels of TNF-α and IL-1β decreased significantly compared with the model group (P < 0.05). These results indicate that the deer antler polypeptide can inhibit the release of pro-inflammatory cytokines in the later stages of wound healing. Compared with the deer antler polypeptide obtained in Example 1, the hydroxyproline content (5.37±0.15) of the deer antler polypeptide obtained in Comparative Example 3 was relatively low, while the levels of inflammatory factors IL-1β and TNF-α at the wound site were significantly higher, indicating that trypsin and neutral protease enzymatic hydrolysis of the deer antler polypeptide has a significant ability to promote wound closure and alleviate inflammation.

[0041] Table 2: Effects of deer antler polypeptides on wound immune regulatory factors and collagen formation

[0042] Group Hydroxyproline (μg / mg) IL-1β (pg / mg) TNF-α (pg / mg) Blank control group 4.59±0.35 45.3±5.2 220.9±10.2 Deer antler polypeptide group (Example 1) <![CDATA[6.16±0.09 * ]]> <![CDATA[37.7±7.2 * ]]> <![CDATA[193.8±17.3 * ]]> Deer antler polypeptide group (Comparative Example 3) 5.37±0.15 <![CDATA[38.2±4.3 * ]]> <![CDATA[199.8±21.6 * ]]>

[0043] Compared with the blank control, * P < 0.05 ** P < 0.05.

[0044] Therefore, the deer antler polypeptide extract provided by this invention has significant effects in promoting wound healing and skin repair. It can induce the production of protein peptide Pro-Hyp and various inflammatory cytokines at the wound site, promote collagen synthesis at the wound site, prevent scar formation, and has multiple effects such as immunomodulation and promoting epidermal re-epithelialization, rapidly forming a closed space to prevent wound infection.

[0045] Example 6: Liquid chromatography separation and purification of deer antler active peptides

[0046] Deer antler peptides were separated and purified by reversed-phase liquid chromatography (RP-HPLC) using a ZORBAX Eclipse XDB-C18 column (4.6 mm × 250 mm, 5 μm). The mobile phase was water (0.1% TFA) and the mobile phase was acetonitrile. Linear elution was performed under the following conditions: acetonitrile (0% → 75%, 0–60 min), flow rate 0.8 mL / min, and detection wavelength 214 nm. The peptides were collected and their sequences identified based on the chromatograms.

[0047] The components obtained by liquid chromatography separation were identified by mass spectrometry, and the amino acid sequence that promotes wound healing was GGYDESMPDPLPEFTE (GE-16).

[0048] Table 3: Wound Healing Rate Table

[0049] Group wound healing rate Blank control group 33.3±4.5% Deer antler polypeptide group (Example 1) <![CDATA[76.9±10.1% ** ]]> GE-16 <![CDATA[89.2±5.3% ** ]]>

[0050] Compared with the blank control, * P < 0.05 ** P < 0.05.

[0051] The peptide enhanced the wound healing ability, with a wound healing rate of 89.2% (Table 3), which was significantly different from the deer antler peptide group in Example 1 (P < 0.05), indicating that GE-16 is the main component in the deer antler peptide that promotes wound healing.

Claims

1. A deer antler polypeptide, characterized in that, The amino acid sequence of the deer antler polypeptide is SEQ ID NO:

1.

2. The use of the deer antler polypeptide according to claim 1 in the preparation of a drug that promotes wound healing.

3. A pharmaceutical composition, characterized in that, The pharmaceutical composition comprises the deer antler polypeptide of claim 1 and pharmaceutically acceptable excipients.